Fidia Pharma USA, Inc. will be exhibiting at the Annual Meeting of the American Academy of…

New addition in the company's dermatological portfolio

Abano Terme (Italy) and Milan (Italy) April 3, 2013 - Fidia Farmaceutici S.p.A. (Abano Terme, Italy)…

Fidia Pharma USA Inc, to distribute the product online

Hyalo GYN® supplements the body's natural hydrating function, and is intended for use as a hydrating…

Organizzato da Fidia con il patrocinio dell'Università degli Studi di Padova

Patrocinato dall'Universita' di Padova e promosso da Fidia farmaceutici, il convegno trattera'…

Commercial rights to Hyalgan transitioned from Sanofi back to Fidia, the brand's owner and manufacturer

Wholly-owned subsidiary, Fidia Pharma USA Inc, engages Interpace BioPharma, LLC. to handle distribution and promotional support

PARSIPPANY, N.J., Sept. 26, 2011 /PRNewswire/ -- Fidia Farmaceutici S.p.A. ("Fidia") announced today…

Genzyme's EP patent has been finally revoked in its entirety by the EPO Board of Appeal

Fidia Farmaceutici S.p.A. (Abano Terme, Italy) announces that the opposition they filed against…

The U.S. FDA has accepted the IND application for the development of a 140mg Diclofenac Sodium Matrix Patch for the topical treatment of acute pain

Applied Pharma Research sa (APR), and Fidia Farmaceutici SpA (Fidia) today announced that the U.S.…


Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- ophthalmology
- wound care
- dermatology
- neurology
- dermo-aesthetics